Access cutting-edge metastatic cancer treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access metastatic cancer specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related metastatic cancer treatment provided free
This is an open-label, dose escalation and expansion study to evaluate the safety, tolerability, PK, and biological activity of VT3989 administered, alone or in combination, once daily in patients with mesothelioma and/or metastatic solid tumors that are resistant to standard therapy or for which no effective standard therapy is available.
Sponsor: Vivace Therapeutics, Inc
Check if you qualify for this metastatic cancer clinical trial in San Francisco, CA
If you're searching for metastatic cancer treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced metastatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.